
Loading, please wait...

Loading, please wait...

Clinicians frequently encounter absence seizures in pediatric patients with idiopathic generalized epilepsies. Manual review of prolonged EEG records is often laborious and time-consuming. However, automated absence seizure detection offers a potential solution to improve laboratory workflow and clinical efficiency.
A recent study published in the Journal of Clinical Neurophysiology evaluated the Persyst software's performance in a pediatric cohort. Researchers analyzed eighty-one EEG records from sixty-nine patients to compare different software modules. They specifically focused on the seizure detection module and the spikeburst module, which identifies clusters of interictal epileptiform discharges.
The study results revealed that the seizure detection module achieved a sensitivity of 78%. In contrast, the spikeburst module showed varying results based on the duration settings. Specifically, a 1-second threshold reached a high sensitivity of 95% but resulted in 23 false positives every 24 hours. Increasing the threshold to 3 seconds reduced false positives to zero, yet the sensitivity dropped to 61%.
Consequently, the researchers determined that a 2-second spikeburst threshold represents the most feasible compromise. This setting offers a sensitivity of 77% with only one false positive per day. Moreover, both software modules performed exceptionally well for longer events, reaching 99% sensitivity for seizures exceeding nine seconds. Most false positives occurred due to interictal discharges rather than actual seizures.
Ultimately, these automated tools assist neurologists in triaging large volumes of EEG data. By using the 2-second spikeburst setting, clinicians can maintain high detection accuracy while minimizing the burden of reviewing false alarms. This efficiency gain is particularly valuable in high-volume pediatric neurology centers where rapid interpretation is essential for treatment adjustments.
The spikeburst module with a 2-second threshold duration is recommended. It provides a balanced performance with 77% sensitivity and a very low false positive rate of one per 24 hours.
The software is highly accurate for longer events. Both the seizure detection and spikeburst modules reach a 99% detection rate for absence seizures lasting more than 9 seconds.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. Refer to the latest local and national guidelines for clinical practice.
References
Reus EEM et al. Performance of Automated Detection Software in Absence Seizures. J Clin Neurophysiol. 2026 Feb 19. doi: 10.1097/WNP.0000000000001242. PMID: 41712934.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study evaluates Persyst's automated detection software for absence seizures in pediatric EEGs, identifying the 2-second module as the most usable clinical...
8 months ago

Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today

A cross-sectional study reveals that maternal RSV vaccination coverage reached only 43.7% in Argentina, with maternal vaccine knowledge being the sole independent predictor of uptake. Clinicians play a crucial role in eliminating informational and structural barriers to optimize infant health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday